InvestorsHub Logo
Followers 23
Posts 911
Boards Moderated 0
Alias Born 10/22/2015

Re: OFP post# 99708

Wednesday, 04/05/2017 10:51:33 PM

Wednesday, April 05, 2017 10:51:33 PM

Post# of 461441
This is Ph 2a trial, not Ph 2b nor Ph 3. It isn't powered for statistical significance and the dosages given aren't optimized. Efficacy isn't a primary endpoint. Nonetheless, there were favorable efficacy scores over time, which was unexpected.

Unfortunately the trial didn't show cure of Alzheimers after just 3 months like one of Anavex's competitors has demonstrated.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News